NEW DELHI: India on Friday issued its first official response to reports that US President Donald Trump announcing imposition of tariffs of up to 100 per cent on imports of branded and patented pharmaceutical drugs from October 1. During the weekly briefing, MEA's official spokesperson Randhir Jaiswal said, “We saw a notice yesterday on social media that talked about new tariffs. We've seen the report on pharma and other products, and the relevant ministry and department are closely monitoring the matter and examining its impact.” While Jaiswal did not provide details on any immediate diplomatic or trade responses, he clarified that relevant ministry officials have taken cognizance and talks will be held with them for specific details. The development comes amid growing conce

See Full Page